If you're in Orlando, FL for the #APhA2024 Annual Meeting & Expo come join us bright and early Saturday morning for our talk: Optimizing Care for Chronic Worsening Heart Failure! Thanks American Pharmacists Association and PTCE for the opportunity!

Had a great time presenting at #APhA2024 !! Thank you PTCE and American Pharmacists Association for this awesome opportunity!

🆕 2024 ACC/AHA/Multisociety Guideline for the Management of Lower Extremity PAD provides recommendations to guide clinicians in the Tx of patients with lower extremity PAD across its multiple clinical presentation subsets. bit.ly/3K0ypes #JACC #cvPAD Heather L Gornik

Presented at #ERA24: FLOW trial: In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. nej.md/44U3slP

Query to my cardiac #PharmD's in #academia -> do you all still teach students about MONA-B, MONA BASH, or did you transition to THROMBINS2? Reflections ahead of the incoming 2024-25 PGY1 residency class. ACCP Cardiology PRN

This is a very cool read about Akira Endo, the father of #Statin drugs, who recently passed, along with a brief history of discovering statins. His contribution to medicine saved countless lives! mdedge.com/cardiology/art…

IDK how this has gone under the radar these past 2 years. Obicetracib added to statin therapy reduced LDL-C, ApoB, Lp(a), and increased HDL-C!? Best of all worlds? Although, recall the J-shaped curve w/ HDL-C. Looking forward to long-term safety data! nature.com/articles/s4159…

I'm all about the CV Team, not one discipline over another. But, love that this meta-analysis identifies pharmacists & CHWs as the most effective in lowering BP. Real issue is the non-evidence barriers highlighted by Ross Tsuyuki, BSc(Pharm), PharmD, MSc, FACC, FCAHS in his editorial. ahajournals.org/doi/epdf/10.11…

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF dlvr.it/TBX0wb

Excited to be part of the team and for all the great episodes soon to come!

Very interesting complex patient case on iForumRx Multiple Comorbidities and Too Many Meds - sounds like many of the vets I help follow up on. I think simplifying drug regimens is a top priority, and the practice of "deprescribing" is underutilized. iforumrx.org/complex-patien…

PSA for treating diuretic-resistant patients with worsening HF: -Dehydration is NOT an allergy; don’t list it as such for SGLT2i. -Discharging HF patients on daily metolazone plus high dose loop is not great; it's a path to an AKI. Point being made: Consider SGLT2i rechallenge.

ABYSS: Safety Signal Seen When Beta-Blockers Stopped in Post-MI Patients dlvr.it/TCYk1R

🔥🔥🔥 An essential resource! Outstanding review on steroidal versus nonsteroidal MRA in HF. All trials, mechanisms, profiles. Andrew J Sauer MD Harriette Van Spall, MD MPH Andrew P. Ambrosy, MD #JACCHF JACC Journals jacc.org/doi/10.1016/j.…